Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis
UpdatedJun 30, 2022
DataAggregated Company Financials
Companies16
- 7D-2.1%
- 3M10.2%
- 1Y-10.2%
- YTD-2.7%
The Clinical Research and Equipment industry is up 2.4% in the last week, with Precision System Science up 36%. In the same time, CellSource was down 5.3%. However, the industry is down 8.4% over the past year. Earnings are forecast to grow by 8.5% annually.
Industry Valuation and Performance
Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Fri, 01 Jul 2022 | JP¥279.3b | JP¥152.8b | JP¥10.9b | 17.5x |
| Sun, 29 May 2022 | JP¥252.1b | JP¥152.7b | JP¥10.9b | 18.2x |
| Tue, 26 Apr 2022 | JP¥247.9b | JP¥144.9b | JP¥10.6b | 19.8x |
| Thu, 24 Mar 2022 | JP¥229.9b | JP¥144.9b | JP¥10.6b | 20.8x |
| Sat, 19 Feb 2022 | JP¥239.3b | JP¥144.7b | JP¥10.5b | 18.7x |
| Mon, 17 Jan 2022 | JP¥259.5b | JP¥136.0b | JP¥6.8b | 20.9x |
| Wed, 15 Dec 2021 | JP¥288.3b | JP¥135.7b | JP¥6.9b | 23.6x |
| Fri, 12 Nov 2021 | JP¥411.4b | JP¥207.5b | JP¥10.2b | 25.9x |
| Sun, 10 Oct 2021 | JP¥364.1b | JP¥198.7b | JP¥8.1b | 25.9x |
| Tue, 07 Sep 2021 | JP¥367.6b | JP¥202.2b | JP¥5.2b | 25.3x |
| Thu, 05 Aug 2021 | JP¥343.6b | JP¥201.8b | JP¥5.0b | 24.9x |
| Sun, 09 May 2021 | JP¥300.8b | JP¥194.0b | JP¥2.5b | 23.2x |
| Wed, 10 Feb 2021 | JP¥284.1b | JP¥191.7b | JP¥152.2m | 31.6x |
| Tue, 03 Nov 2020 | JP¥274.4b | JP¥190.0b | -JP¥434,535,000.00 | 49.2x |
| Fri, 07 Aug 2020 | JP¥299.4b | JP¥189.8b | JP¥2.0b | 18.2x |
| Thu, 30 Apr 2020 | JP¥234.1b | JP¥193.4b | JP¥2.7b | 19.9x |
| Sun, 02 Feb 2020 | JP¥254.9b | JP¥190.2b | JP¥1.9b | 27.2x |
| Wed, 06 Nov 2019 | JP¥233.4b | JP¥187.0b | JP¥2.1b | 30.7x |
| Sat, 10 Aug 2019 | JP¥243.1b | JP¥184.1b | JP¥1.5b | 33.4x |
Median PE Ratio
31.8x
Current Industry PE
- Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 25.7x which is lower than its 3-year average PE of 192x.
- The 3-year average PS ratio of 1.6x is lower than the industry's current PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have grown 92% per year over the last three years.
- Meanwhile revenues for these companies have declined 6.0% per year.
- This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.
Industry Comparison
How does Japanese Clinical Research and Equipment compare with similar industries?
| JP Market | 0.26% | |
| Healthcare | 0.76% | |
| Life Sciences | -2.10% | |
| Clinical Research and Equipment | -2.10% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 7707 Precision System Science | JP¥520.00 | 12.3% +JP¥1.6b | -37.0% | PE43.3x | |
| 4570 Immuno-Biological Laboratories | JP¥460.00 | 42.9% +JP¥1.3b | -12.4% | PS6.6x | |
| 2183 Linical | JP¥806.00 | 4.1% +JP¥722.8m | -11.6% | PE23x | |
| 2309 CMIC HOLDINGS | JP¥1.43k | 1.3% +JP¥319.8m | -12.0% | PE5.9x | |
| 2397 DNA Chip Research | JP¥509.00 | 5.2% +JP¥146.7m | -26.1% | PS7x |